FHIR IG analytics| Package | navify.fhir.r5.rdc |
| Resource Type | Bundle |
| Id | rdc-Bundle-response-AGP-report.json |
| FHIR Version | R5 |
No resources found
No resources found
No narrative content found in resource
FHIR
FHIRsmith{
"resourceType": "Bundle",
"id": "rdc-Bundle-response-AGP-report",
"type": "batch-response",
"entry": [
{
"response": {
"status": "200 OK"
}
},
{
"fullUrl": "urn:uuid:550e8400-e29b-41d4-a716-446655440000",
"resource": {
"resourceType": "DiagnosticReport",
"id": "rdc-DiagnosticReport-agp-report",
"meta": {
"profile": [
"https://roche.com/fhir/iop/StructureDefinition/rdc-DiagnosticReport"
]
},
"status": "final",
"code": {
"coding": [
{
"code": "R7786-7",
"system": "https://roche.com/fhir/CodeSystem/general",
"display": "CGM Ambulatory Glucose Profile (AGP) During Reporting Period"
}
]
},
"contained": [
{
"resourceType": "Observation",
"id": "Obs-1",
"meta": {
"profile": [
"https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-CGM"
]
},
"status": "final",
"code": {
"coding": [
{
"code": "434910001",
"system": "http://snomed.info/sct",
"display": "Interstitial fluid glucose concentration (observable entity)"
}
]
},
"subject": {
"reference": "Patient/34605fdc-74aa-4587-a5f0-92e6c5f64527"
},
"effectivePeriod": {
"start": "2020-10-14T02:01:00+01:00",
"end": "2020-10-14T02:06:00+01:00"
},
"valueSampledData": {
"origin": {
"value": 0,
"code": "mg/dL",
"system": "http://unitsofmeasure.org",
"unit": "mg/dL"
},
"interval": 60000,
"intervalUnit": "ms",
"dimensions": 1,
"data": "100 99 89 89",
"extension": [
{
"url": "https://roche.com/fhir/iop/StructureDefinition/ext-CGMFlags",
"valueString": "HI; X; X; LO"
}
]
},
"extension": [
{
"url": "https://roche.com/fhir/iop/StructureDefinition/ext-CalibrationStatus",
"valueString": "calibrated"
}
],
"device": {
"reference": "Device/6ae8bff3-910a-419d-96f6-de0e8fd1d64d"
}
},
{
"resourceType": "Observation",
"id": "Obs-2",
"meta": {
"profile": [
"https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-CGM"
]
},
"status": "final",
"code": {
"coding": [
{
"code": "434910001",
"system": "http://snomed.info/sct",
"display": "Interstitial fluid glucose concentration (observable entity)"
}
]
},
"subject": {
"reference": "Patient/34605fdc-74aa-4587-a5f0-92e6c5f64527"
},
"effectivePeriod": {
"start": "2020-10-15T02:01:00+01:00",
"end": "2020-10-15T02:06:00+01:00"
},
"valueSampledData": {
"origin": {
"value": 0,
"code": "mg/dL",
"system": "http://unitsofmeasure.org",
"unit": "mg/dL"
},
"interval": 60000,
"intervalUnit": "ms",
"dimensions": 1,
"data": "100 99 89 89",
"extension": [
{
"url": "https://roche.com/fhir/iop/StructureDefinition/ext-CGMFlags",
"valueString": "HI; X; X; LO"
}
]
},
"extension": [
{
"url": "https://roche.com/fhir/iop/StructureDefinition/ext-CalibrationStatus",
"valueString": "calibrated"
}
],
"device": {
"reference": "Device/6ae8bff3-910a-419d-96f6-de0e8fd1d64d"
}
},
{
"resourceType": "Observation",
"id": "Obs-3",
"meta": {
"profile": [
"https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report"
]
},
"status": "final",
"code": {
"coding": [
{
"code": "97507-8",
"system": "http://loinc.org",
"display": "Average glucose [Mass/ volume] in Interstitial fluid during Reporting Period"
}
]
},
"effectivePeriod": {
"start": "2020-10-15T02:01:00+01:00",
"end": "2020-10-15T02:06:00+01:00"
},
"valueQuantity": {
"system": "http://unitsofmeasure.org",
"code": "mg/dL",
"unit": "mg/dL",
"value": 136
}
},
{
"resourceType": "Observation",
"id": "Obs-4",
"meta": {
"profile": [
"https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report"
]
},
"status": "final",
"code": {
"coding": [
{
"code": "R9599-2",
"system": "https://roche.com/fhir/CodeSystem/general",
"display": "CGM Glycemic Variability (%GV), during reporting period"
}
]
},
"effectivePeriod": {
"start": "2020-10-15T02:01:00+01:00",
"end": "2020-10-15T02:06:00+01:00"
},
"valueQuantity": {
"system": "http://unitsofmeasure.org",
"code": "mg/dL",
"unit": "mg/dL",
"value": 35.5
}
},
{
"resourceType": "Observation",
"id": "Obs-5",
"meta": {
"profile": [
"https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report"
]
},
"status": "final",
"code": {
"coding": [
{
"code": "97504-5",
"system": "http://loinc.org",
"display": "Percent sensor usage"
}
]
},
"effectivePeriod": {
"start": "2020-10-15T02:01:00+01:00",
"end": "2020-10-15T02:06:00+01:00"
},
"valueQuantity": {
"system": "http://unitsofmeasure.org",
"code": "%",
"unit": "%",
"value": 100
}
},
{
"resourceType": "Observation",
"id": "Obs-6",
"meta": {
"profile": [
"https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report"
]
},
"status": "final",
"code": {
"coding": [
{
"code": "97506-0",
"system": "http://loinc.org",
"display": "Glucose management indicator"
}
]
},
"effectivePeriod": {
"start": "2020-10-15T02:01:00+01:00",
"end": "2020-10-15T02:06:00+01:00"
},
"valueQuantity": {
"system": "http://unitsofmeasure.org",
"code": "%",
"unit": "%",
"value": 6.6
}
},
{
"resourceType": "Observation",
"id": "Obs-7",
"meta": {
"profile": [
"https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report"
]
},
"status": "final",
"code": {
"coding": [
{
"code": "104639-0",
"system": "http://loinc.org",
"display": "Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent above target glucose range, very high (TAR-VH >250 mg/dL (>13.9 mmol/L) (hyperglycemic) during reporting period"
}
]
},
"effectivePeriod": {
"start": "2020-10-15T02:01:00+01:00",
"end": "2020-10-15T02:06:00+01:00"
},
"valueQuantity": {
"system": "http://unitsofmeasure.org",
"code": "%",
"unit": "%",
"value": 3
}
},
{
"resourceType": "Observation",
"id": "Obs-8",
"meta": {
"profile": [
"https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report"
]
},
"status": "final",
"code": {
"coding": [
{
"code": "104640-8",
"system": "http://loinc.org",
"display": "Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent above target glucose range, high (TAR-H) 181-250 mg/ dL (10.1-13.9 mmol/L) (hyperglycemic) during reporting period"
}
]
},
"effectivePeriod": {
"start": "2020-10-15T02:01:00+01:00",
"end": "2020-10-15T02:06:00+01:00"
},
"valueQuantity": {
"system": "http://unitsofmeasure.org",
"code": "%",
"unit": "%",
"value": 14
}
},
{
"resourceType": "Observation",
"id": "Obs-9",
"meta": {
"profile": [
"https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report"
]
},
"status": "final",
"code": {
"coding": [
{
"code": "97510-2",
"system": "http://loinc.org",
"display": "Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent in target glucose range (70-180 mg/dL [3.9-10.0 mmol/L]) during reporting period. The primary goal for effective and safe glucose control is to increase the TIR whil"
}
]
},
"effectivePeriod": {
"start": "2020-10-15T02:01:00+01:00",
"end": "2020-10-15T02:06:00+01:00"
},
"valueQuantity": {
"system": "http://unitsofmeasure.org",
"code": "%",
"unit": "%",
"value": 78
}
},
{
"resourceType": "Observation",
"id": "Obs-10",
"meta": {
"profile": [
"https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report"
]
},
"status": "final",
"code": {
"coding": [
{
"code": "104641-6",
"system": "http://loinc.org",
"display": "Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent below target glucose range, low (TBR-L) 54-69 mg/dL (3.0-3.8 mmol/L) (hypoglycemic) during reporting period"
}
]
},
"effectivePeriod": {
"start": "2020-10-15T02:01:00+01:00",
"end": "2020-10-15T02:06:00+01:00"
},
"valueQuantity": {
"system": "http://unitsofmeasure.org",
"code": "%",
"unit": "%",
"value": 5
}
},
{
"resourceType": "Observation",
"id": "Obs-11",
"meta": {
"profile": [
"https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report"
]
},
"status": "final",
"code": {
"coding": [
{
"code": "104642-4",
"system": "http://loinc.org",
"display": "Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent below target glucose range, very low (TBR-VL) <54 mg/dL (<3.0 mmol/L) (hypoglycemic) during reporting period"
}
]
},
"effectivePeriod": {
"start": "2020-10-15T02:01:00+01:00",
"end": "2020-10-15T02:06:00+01:00"
},
"valueQuantity": {
"system": "http://unitsofmeasure.org",
"code": "%",
"unit": "%",
"value": 0
}
}
],
"subject": {
"reference": "Patient-Reference"
},
"effectivePeriod": {
"start": "2023-10-03T06:32:00+01:00",
"end": "2023-10-03T07:30:00+01:00"
},
"performer": [
{
"reference": "Organization-Reference"
},
{
"reference": "Practitioner-Reference"
}
],
"result": [
{
"reference": "#Obs-1"
},
{
"reference": "#Obs-2"
},
{
"reference": "#Obs-3"
},
{
"reference": "#Obs-4"
},
{
"reference": "#Obs-5"
},
{
"reference": "#Obs-6"
},
{
"reference": "#Obs-7"
},
{
"reference": "#Obs-8"
},
{
"reference": "#Obs-9"
},
{
"reference": "#Obs-10"
},
{
"reference": "#Obs-11"
}
],
"presentedForm": [
{
"url": "https://aws-cloud-location-of-AGP-Report",
"data": "QUdQIHJlcG9ydA==",
"hash": "2c9fa2fc8f4fd1b3184821e27dfc0b6960724633",
"contentType": "application/pdf",
"creation": "2023-10-03T07:30:00+01:00",
"title": "AGP-Report"
}
]
},
"response": {
"status": "200 OK",
"location": "DiagnosticReport/550e8400-e29b-41d4-a716-446655440000"
}
}
]
}